Louise Bicknell

Preparation of Parliamentary answers on Evusheld

Response by Department of Health and Social Care to Louise Bicknell on 26 May 2023.

Awaiting classification.

Dear Ms Bicknell, With apologies for the delay, please find attached the Department of Health and Social Care's response to your recent FOI request...

Preparation of the COVID-19 Response: Living with COVID-19 by HMG and failing to address available prophylaxis treatments

Response by Department of Health and Social Care to Louise Bicknell on 17 May 2023.

Awaiting classification.

Dear Ms Bicknell, Thank you for your request of 16 April under the Freedom of Information Act (our ref:FOI-1449046) I am writing to inform you tha...

Testing of Evusheld by UKHSA: inconsistency in information provided in a correction to written parliamentary answers and under my FOIA request

Response by UK Health Security Agency to Louise Bicknell on 10 May 2023.

Awaiting classification.

Dear Louise Bicknell, We acknowledge receipt of your email, which will be treated as a request for an internal review, following your request fo...

Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 May 2023.

Refused.

To be referred to the ICO

Therapeutics Clinical Review Panel meetings and minutes

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 May 2023.

Refused.

To be referred to the ICO

Review of CMDUs by the Antivirals and Therapeutics Task Force

Response by Department of Health and Social Care to Louise Bicknell on 4 May 2023.

Awaiting classification.

Dear Ms Bicknell, Your requested internal review of FOI-1440905 is now complete. Please see the attached letter for the outcome. Yours sincerely,...

Communication and discussion of Evusheld testing results May 2022 onwards

Response by UK Health Security Agency to Louise Bicknell on 18 April 2023.

Awaiting classification.

Dear Louise Bicknell, Please find attached the UK Health Security Agency's response to your request. Yours sincerely, Information Rights...

Antibody Testing for COVID-19

Response by Department of Health and Social Care to Louise Bicknell on 18 April 2023.

Awaiting classification.

Dear Ms Bicknell, Your requested internal review of FOI-1437593 is now complete. Please see the attached letter for the outcome. Once again, pleas...

Preparation of the COVID-19 Response: Living with COVID-19 by HMG in respect of prophylaxis treatments

Response by Department of Health and Social Care to Louise Bicknell on 14 April 2023.

Refused.

Dear Ms Bicknell, Please find attached the Department of Health and Social Care's response to your recent FOI request (our ref: FOI-1440831). Your...

COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request

Internal review request sent to NHS England by Louise Bicknell on 12 April 2023.

Awaiting internal review.

Please pass this on to the person who conducts Freedom of Information reviews. I am writing to request an internal review of NHS England's handling o...

Changes to the shielding policy

Response by Department of Health and Social Care to Louise Bicknell on 31 March 2023.

Successful.

Dear Ms Bicknell, Your requested internal review of FOI-1429069 is now complete. Please see the attached letter for the outcome. Yours sincerely,...

Communications between the Chief Medical Officer and the Scientific Advisory Group for Emergencies on the use of prophylaxis treatments including Evusheld

Response by NHS England to Louise Bicknell on 31 March 2023.

Long overdue.

Dear Louise Bicknell, We are writing with regard to your Freedom of Information (FOI) request dated 2 March 2023. Please accept our apologies for...

Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer

Internal review request sent to NHS Improvement by Louise Bicknell on 30 March 2023.

Awaiting internal review.

Dear NHS Improvement/NHS England Please pass this on to the person who conducts Freedom of Information reviews. Thank you for your response Plea...

Testing of Sotrovimab/Xevudy

Response by UK Health Security Agency to Louise Bicknell on 10 March 2023.

Partially successful.

Dear Louise Bicknell, Please find attached the UK Health Security Agency's response to your request. Yours sincerely, Information Rights Team P...

CMDU performance South East London follow up FOI 107092

Request to Guy's and St Thomas' NHS Foundation Trust by Louise Bicknell. Annotated by Louise Bicknell on 2 March 2023.

Partially successful.

I view of the time elapsed and the answers being provided promptly by other CMDUs to these questions I decided not to follow up. A lesson for the futu...

Meeting of the Antivirals and Therapeutics Taskforce Programme Board 2 February 2023

Response by Department of Health and Social Care to Louise Bicknell on 28 February 2023.

Refused.

This is an acknowledgement - please do not reply to this email. Thank you for contacting the Department of Health and Social Care. If your enquiry...

Meetings of the Therapeutics Clinical Review Panel from 1 June 2022 to date

Response by Department of Health and Social Care to Louise Bicknell on 28 February 2023.

Refused.

This is an acknowledgement - please do not reply to this email. Thank you for contacting the Department of Health and Social Care. If your enquiry...

Meetings of the Antivirals and Therapeutics Taskforce Engagement Board after 20 July 2022 to date

Response by Department of Health and Social Care to Louise Bicknell on 28 February 2023.

Refused.

This is an acknowledgement - please do not reply to this email. Thank you for contacting the Department of Health and Social Care. If your enquiry...

Meetings of the Prophylaxis Oversight Group from 1 June 2022 to date

Response by Department of Health and Social Care to Louise Bicknell on 28 February 2023.

Refused.

This is an acknowledgement - please do not reply to this email. Thank you for contacting the Department of Health and Social Care. If your enquiry...

COVID-19 nMABs Access and Policy National Expert Group - Evusheld

Response by NHS England to Louise Bicknell on 24 February 2023.

Partially successful.

Dear Louise Bicknell, We refer to your email of 12 February 2023 in which you raised further queries in respect of information provided to you by NHS...

Date of decision not to proceed with the order to procure Evusheld

Response by UK Health Security Agency to Louise Bicknell on 20 February 2023.

Successful.

Dear Louise Bicknell, Thank you for your email. We can confirm that 25 February 2021 is the correct date as per our previous response to y...

Correspondence on the failure of the DHSC to procure antiviral and prophylaxis treatments between the DHSC and the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK

Response by Department of Health and Social Care to Louise Bicknell on 20 February 2023.

Successful.

Dear Ms Bicknell, Please find attached the Department of Health and Social Care's response to your recent FOI request (our ref: FOI-1434961). Your...

Antivirals and Therapeutics TaskForce agendas and decision logs

Response by Department of Health and Social Care to Louise Bicknell on 20 February 2023.

Refused.

Dear Ms Bicknell, Please find attached the Department of Health and Social Care's response to your recent FOI request (our ref: FOI-1435834). Your...

Dates of meetings of the Antivirals and Therapeutics Taskforce 2023

Response by Department of Health and Social Care to Louise Bicknell on 20 February 2023.

Partially successful.

Dear Ms Bicknell, Your requested internal review of FOI-1435071 is now complete. Please see the attached letter for the outcome. Yours sincerely,...

Antivirals and Therapeutics Taskforce SB and PB agendas and action/decision logs

Response by Department of Health and Social Care to Louise Bicknell on 14 February 2023.

Partially successful.

Dear Ms Bicknell, Your requested internal review of FOI-1431752 is now complete. Please see the attached letter for the outcome. Yours sincerely,...

Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 May 2023.

Refused.

To be referred to the ICO

Therapeutics Clinical Review Panel meetings and minutes

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 May 2023.

Refused.

To be referred to the ICO

COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 26 March 2023.

Awaiting internal review.

ICO issued decision notice on 6 February for failure to respond within the statutory time limit. Gave 35 working days to reply. Information still out...

CMDU performance South East London follow up FOI 107092

Request to Guy's and St Thomas' NHS Foundation Trust by Louise Bicknell. Annotated by Louise Bicknell on 2 March 2023.

Partially successful.

I view of the time elapsed and the answers being provided promptly by other CMDUs to these questions I decided not to follow up. A lesson for the futu...

Sajid Javid’s letter of 27 September 2021 changing the COVID shielding policy for the clinically extremely vulnerable

Request to Department of Health and Social Care by Penelope Crouch. Annotated by Louise Bicknell on 25 February 2023.

Awaiting classification.

Matter is with the ICO to determine as relevant information has been totally redacted and not provided on time

COVID-19 nMABs Access and Policy National Expert Group - Evusheld

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 11 February 2023.

Partially successful.

ICO required a response. This was received on 8 February. As detailed above parts were missing. Requested internal review on 11 February 2023

COVID-19 nMABs Access and Policy National Expert Group - Evusheld

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 28 December 2022.

Partially successful.

28/12/22 Sent to ICO for failure to respond to their response request

COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 26 December 2022.

Awaiting internal review.

Referred to ICO for failure to respond 26/12/22

Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 9 December 2022.

Refused.

Refined request submitted to replace this

Antivirals and Therapeutics Task Force

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 9 December 2022.

Refused.

Refined request submitted 9 December 2022

Antivirals and therapeutics task force - Evusheld

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 December 2022.

Partially successful.

Sent to ICO for failure to respond on 5/12/22

Communications mentioning Evusheld between Professor James Palmer and Charlotte Taylor

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 29 November 2022.

Partially successful.

The internal review was denied, but suggested revised question. I am following this up, but will leave this open for the ICO to consider if need be

Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

Referred to the ICO for failure to respond on 26/11/2022

Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer

Request to NHS Improvement by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

Referred tot he ICO for failure to reply on 26/11/22

Communications on Evusheld between Professor James Palmer and Charlotte Taylor

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

Referred tot he ICO for failure to respond on 26/11/22

Communications mentioning Evusheld between Professor James Palmer and Charlotte Taylor

Request to NHS Improvement by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

REferred to the ICO for failure to respond 26/11/22

Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

Referred to the ICO on 26/11/22 for failure to reply

Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer

Request to NHS Improvement by Louise Bicknell. Annotated by Louise Bicknell on 26 November 2022.

Awaiting internal review.

Referred to the ICO for failure to respond 26/11/22

Antivirals and therapeutics task force - Evusheld

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 21 November 2022.

Partially successful.

On 20th day after I requested an internal review they ask for 7 - 10 days more!

Prophylaxis Oversight Group - Evusheld

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 17 November 2022.

Partially successful.

Response due 24/11/22 ICO

COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 17 November 2022.

Awaiting internal review.

Referred to the ICO on 9/11/22 Response due 27/11/22

COVID-19 nMABs Access and Policy National Expert Group - Evusheld

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 17 November 2022.

Partially successful.

Referred to the ICO on 9/11/22 Given until 27/11 to respond

COVID-19 nMABs Access and Policy National Expert Group - Evusheld

Request to NHS England by Louise Bicknell. Annotated by Louise Bicknell on 8 November 2022.

Partially successful.

Referred to the Information Commissioner for failure to respond on 8/11/22

Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 5 November 2022.

Partially successful.

In the absence of any response to this FOI I have referred this to the Information Commissioner on 5/11/22

Prophylaxis Oversight Group - Evusheld

Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on 3 November 2022.

Partially successful.

Referred to the ICO for failure to answer on 2/11/22

WhatDoTheyKnow

Track this person

On this page

This person's Freedom of Information requests (approximately 76)

This person's 37 annotations

WhatDoTheyKnow